Page last updated: 2024-08-24

triazoles and 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin

triazoles has been researched along with 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (16.67)	29.6817
2010's	4 (66.67)	24.3611
2020's	1 (16.67)	2.80

Authors

Authors	Studies
Caldas Lopes, E; Chiosis, G; Solit, D	1
Chen, S; Reddy, K; Smith, D; Wang, X; Wong, C	1
Chrysikos, D; Dimopoulos, MA; Papadimitriou, CA; Psaltopoulou, T; Sergentanis, TN; Zagouri, F	1
Ebi, H; Kita, K; Matsumoto, K; Nanjo, S; Takeuchi, S; Tanimoto, A; Yamada, T; Yano, S	1
Seo, YH	1
Hayashi, K; Onda, T; Onidani, K; Sekikawa, S; Shibahara, T; Shiraishi, N; Watanabe, K	1

Reviews

4 review(s) available for triazoles and 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin

Article	Year
Heat shock protein-90 inhibitors: a chronicle from geldanamycin to today's agents. Current opinion in investigational drugs (London, England : 2000), 2006, Volume: 7, Issue:6 Topics: Adenosine Triphosphate; Animals; Antibodies, Monoclonal; Antineoplastic Agents; Benzoquinones; Binding, Competitive; HSP90 Heat-Shock Proteins; Humans; Lactams, Macrocyclic; Molecular Structure; Neoplasms; Protein Conformation; Protein-Tyrosine Kinases; Pyrimidines; Quinones; Triazoles	2006
AKT-aro and HER2-aro, models for de novo resistance to aromatase inhibitors; molecular characterization and inhibitor response studies. Breast cancer research and treatment, 2012, Volume: 134, Issue:2 Topics: Antineoplastic Agents; Aromatase; Aromatase Inhibitors; Benzoquinones; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Disease-Free Survival; Drug Resistance, Neoplasm; Drug Synergism; Estradiol; Extracellular Signal-Regulated MAP Kinases; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; HSP90 Heat-Shock Proteins; Humans; Lactams, Macrocyclic; Letrozole; Nitriles; Proto-Oncogene Proteins c-akt; Receptor, ErbB-2; Receptors, Estrogen; Transcriptional Activation; Triazoles	2012
Hsp90 inhibitors in breast cancer: a systematic review. Breast (Edinburgh, Scotland), 2013, Volume: 22, Issue:5 Topics: Adenine; Antineoplastic Agents; Benzamides; Benzoquinones; Biomarkers, Tumor; Female; Glycine; HSP70 Heat-Shock Proteins; HSP90 Heat-Shock Proteins; Humans; Indazoles; Isoxazoles; Lactams, Macrocyclic; Pyridines; Resorcinols; Triazoles; Triple Negative Breast Neoplasms	2013
Organelle-specific Hsp90 inhibitors. Archives of pharmacal research, 2015, Volume: 38, Issue:9 Topics: Animals; Benzoquinones; HSP90 Heat-Shock Proteins; Humans; Lactams, Macrocyclic; Organelles; Triazoles	2015

Other Studies

2 other study(ies) available for triazoles and 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin

Article	Year
Receptor ligand-triggered resistance to alectinib and its circumvention by Hsp90 inhibition in EML4-ALK lung cancer cells. Oncotarget, 2014, Jul-15, Volume: 5, Issue:13 Topics: Benzoquinones; Blotting, Western; Carbazoles; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Epidermal Growth Factor; ErbB Receptors; Hepatocyte Growth Factor; HSP90 Heat-Shock Proteins; Humans; Lactams, Macrocyclic; Ligands; Lung Neoplasms; Mutation; Oncogene Proteins, Fusion; Phosphorylation; Piperidines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-met; Transforming Growth Factor alpha; Triazoles	2014
Heat shock protein 90 as a molecular target for therapy in oral squamous cell carcinoma: Inhibitory effects of 17‑DMAG and ganetespib on tumor cells. Oncology reports, 2021, Volume: 45, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Animals; Benzoquinones; Cell Line, Tumor; Cell Proliferation; Chemotherapy, Adjuvant; Drug Screening Assays, Antitumor; Female; HSP90 Heat-Shock Proteins; Humans; Lactams, Macrocyclic; Male; Middle Aged; Molecular Targeted Therapy; Mouth Mucosa; Mouth Neoplasms; Prognosis; Squamous Cell Carcinoma of Head and Neck; Survival Rate; Triazoles	2021

Article

Year

Receptor ligand-triggered resistance to alectinib and its circumvention by Hsp90 inhibition in EML4-ALK lung cancer cells.

Oncotarget, 2014, Jul-15, Volume: 5, Issue:13

Topics: Benzoquinones; Blotting, Western; Carbazoles; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Epidermal Growth Factor; ErbB Receptors; Hepatocyte Growth Factor; HSP90 Heat-Shock Proteins; Humans; Lactams, Macrocyclic; Ligands; Lung Neoplasms; Mutation; Oncogene Proteins, Fusion; Phosphorylation; Piperidines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-met; Transforming Growth Factor alpha; Triazoles

2014

Heat shock protein 90 as a molecular target for therapy in oral squamous cell carcinoma: Inhibitory effects of 17‑DMAG and ganetespib on tumor cells.

Oncology reports, 2021, Volume: 45, Issue:2

Topics: Adult; Aged; Aged, 80 and over; Animals; Benzoquinones; Cell Line, Tumor; Cell Proliferation; Chemotherapy, Adjuvant; Drug Screening Assays, Antitumor; Female; HSP90 Heat-Shock Proteins; Humans; Lactams, Macrocyclic; Male; Middle Aged; Molecular Targeted Therapy; Mouth Mucosa; Mouth Neoplasms; Prognosis; Squamous Cell Carcinoma of Head and Neck; Survival Rate; Triazoles

2021